文献速递生殖医学

磁激活细胞分选非凋亡精子对DNA碎片率及生殖结局的影响:系统综述与荟萃分析

Magnetic-activated cell sorting non-apoptotic sperm selection improves DNA fragmentation and reproductive outcomes: systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2025-07-12

该荟萃分析纳入41项研究,评估MACS对比常规精子选择技术对医学辅助生殖结局、精液参数及精子DNA碎片率的影响。MACS显著降低精子DNA碎片率,但在人工授精周期未显著改善临床妊娠、自然流产或活产率;在卵胞浆内单精子注射周期中,尤其高DNA碎片率患者,MACS显著改善每移植胚胎着床率、临床妊娠率及每胚胎移植活产率。

要点

  • MACS显著降低精子DNA碎片率(均差=-4.32,95%CI -6.29至-2.36)。
  • 人工授精周期中MACS未显著改善临床妊娠、流产或活产率。
  • ICSI周期中MACS改善着床率、临床妊娠率及活产率,尤其高DNA碎片率患者。

核心结论

  • MACS可显著降低精子DNA碎片率,但对人工授精周期生殖结局无显著改善。
  • 在ICSI周期中,MACS对每移植胚胎着床率、临床妊娠率及每胚胎移植活产率有显著改善,尤其在高DNA碎片率患者中。
  • 研究提示MACS可能对特定不育患者亚组有益,需个体化评估并进一步研究以明确临床指征。

研究设计与样本

  • 系统综述与荟萃分析,系统检索PubMed、Web of Science和Scopus,纳入41项符合标准的研究。
  • 比较MACS与常规精子选择技术对医学辅助生殖生殖结局、精液参数及精子DNA碎片率的影响。

主要发现

  • MACS显著降低精子DNA碎片率(均差=-4.32,95%CI -6.29至-2.36;P<0.0001)。
  • 人工授精周期中,MACS对临床妊娠(OR=1.47,95%CI 0.94-2.30,P=0.09)、自然流产(OR=0.92,95%CI 0.40-2.12;P=0.85)及活产(OR=1.55,95%CI 0.78-3.11;P=0.21)无显著改善。
  • ICSI周期中,MACS显著改善每移植胚胎着床率(OR=1.28,95%CI 1.02-1.62;P=0.04)、临床妊娠率(OR=1.41,95%CI 1.19-1.66;P<0.00001)及每胚胎移植活产率(OR=1.31,95%CI 1.09-1.58;P=0.004)。

关键数值与推荐

  • 精子DNA碎片率均差=-4.32(95%CI -6.29至-2.36;P<0.0001)。
  • 人工授精周期临床妊娠OR=1.47(95%CI 0.94-2.30,P=0.09),自然流产OR=0.92(95%CI 0.40-2.12;P=0.85),活产OR=1.55(95%CI 0.78-3.11;P=0.21)。
  • ICSI周期每移植胚胎着床率OR=1.28(95%CI 1.02-1.62;P=0.04),临床妊娠率OR=1.41(95%CI 1.19-1.66;P<0.00001),每胚胎移植活产率OR=1.31(95%CI 1.09-1.58;P=0.004)。

临床怎么用

  • MACS可用于降低精子DNA碎片率,但不应常规用于所有人工授精周期以期望改善妊娠结局。
  • 在ICSI周期中,尤其高DNA碎片率患者,可考虑MACS以改善着床率、临床妊娠率及活产率。
  • 临床应个体化评估MACS指征,并需进一步研究明确其适用人群。

局限性

  • 研究间存在数据异质性。
  • 其他临床参数存在变异性。
  • 研究存在局限性,需进一步研究细化临床指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medically assisted reproduction (MAR) relies on semen quality for success. While conventional sperm selection techniques such as density gradient centrifugation and swim-up are commonly used, they overlook essential molecular sperm characteristics, limiting their effectiveness in predicting the success of MAR. To address this, advanced selection techniques have been developed, including magnetic-activated cell sorting (MACS). This meta-analysis evaluates the effect of MACS compared with conventional sperm selection techniques on MAR reproductive outcomes, seminal parameters, and sperm DNA fragmentation (DNAf) levels. Systematic searches in PubMed, Web of Science and Scopus identified 41 studies that met the inclusion criteria. Results indicate that while MACS reduces sperm DNAf significantly (mean difference = -4.32, 95% CI -6.29 to -2.36; P < 0.0001), it does not significantly improve clinical pregnancy (OR = 1.47, 95% CI 0.94-2.30, P = 0.09), spontaneous miscarriage (OR = 0.92, 95% CI 0.40-2.12; P = 0.85) or live birth (OR = 1.55, 95% CI 0.78-3.11; P = 0.21) rates in artificial insemination cycles. However, in intracytoplasmic sperm injection cycles, MACS demonstrates significant improvements in implantation rate per transferred embryo (OR = 1.28, 95% CI 1.02-1.62; P = 0.04), clinical pregnancy (OR = 1.41, 95% CI 1.19-1.66; P < 0.00001) and live birth (OR = 1.31, 95% CI 1.09-1.58; P = 0.004) rates per embryo transfer, particularly in patients with high DNAf levels. Despite variability in other clinical parameters and study limitations such as data heterogeneity, the study results suggest a potential benefit of MACS in a specific subgroup of infertile patients, underscoring the need for personalized evaluation and further research to refine its clinical indications.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Falquet Guillem M, Pacheco R, Gisbert-Iranzo A, et al. Magnetic-activated cell sorting non-apoptotic sperm selection improves DNA fragmentation and reproductive outcomes: systematic review and meta-analysis. Reprod Biomed Online. 2025. PMID: 41406673. doi:10.1016/j.rbmo.2025.105152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。